Jan van Laar

3.2k total citations · 1 hit paper
57 papers, 1.7k citations indexed

About

Jan van Laar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Jan van Laar has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 14 papers in Rheumatology. Recurrent topics in Jan van Laar's work include Colorectal Cancer Treatments and Studies (13 papers), Ocular Diseases and Behçet’s Syndrome (12 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Jan van Laar is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Ocular Diseases and Behçet’s Syndrome (12 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Jan van Laar collaborates with scholars based in Netherlands, United States and United Kingdom. Jan van Laar's co-authors include Godefridus J. Peters, C.L. van der Wilt, Michael Girschikofsky, Michael B. Jordan, Gritta Janka, Tatiana von Bahr Greenwood, Paul La Rosée, Rafał Machowicz, Gunnar Lachmann and Melissa Hines and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and International Journal of Molecular Sciences.

In The Last Decade

Jan van Laar

55 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

2019 598 citations Paul La Rosée, AnnaCarin Horne et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan van Laar Netherlands	19	599	485	454	344	314	57	1.7k
Patrick Lutz France	26	492 0.8×	326 0.7×	372 0.8×	490 1.4×	374 1.2×	62	2.3k
Pierre‐Yves Berclaz United States	18	187 0.3×	633 1.3×	128 0.3×	147 0.4×	243 0.8×	30	1.6k
Pietro Muretto Italy	27	1.1k 1.9×	244 0.5×	193 0.4×	634 1.8×	528 1.7×	77	2.8k
Anne Huynh France	28	1.6k 2.7×	359 0.7×	141 0.3×	593 1.7×	625 2.0×	130	2.7k
Celalettin Üstün United States	29	1.6k 2.7×	613 1.3×	135 0.3×	664 1.9×	866 2.8×	147	3.0k
David Peace United States	27	650 1.1×	864 1.8×	96 0.2×	767 2.2×	422 1.3×	79	2.1k
Isabel Badell Spain	24	806 1.3×	265 0.5×	79 0.2×	311 0.9×	234 0.7×	108	1.6k
Anne Parker United Kingdom	23	1.0k 1.7×	567 1.2×	195 0.4×	1.1k 3.3×	204 0.6×	54	2.6k
Taeko Ishii Japan	18	440 0.7×	629 1.3×	74 0.2×	388 1.1×	335 1.1×	54	2.0k
Olivier Decaux France	21	1.1k 1.8×	163 0.3×	198 0.4×	559 1.6×	872 2.8×	78	1.8k

Countries citing papers authored by Jan van Laar

Since Specialization

Citations

This map shows the geographic impact of Jan van Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van Laar more than expected).

Fields of papers citing papers by Jan van Laar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan van Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van Laar. The network helps show where Jan van Laar may publish in the future.

Co-authorship network of co-authors of Jan van Laar

This figure shows the co-authorship network connecting the top 25 collaborators of Jan van Laar. A scholar is included among the top collaborators of Jan van Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan van Laar. Jan van Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halteren, Astrid G. S. van, Paul G. Kemps, Yanling Xiao, et al.. (2025). Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms. PubMed. 2(2). 100074–100074. 1 indexed citations

Paridaens, Dion, Paul G. Kemps, Astrid G. S. van Halteren, et al.. (2024). Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations. Clinical Immunology. 265. 110299–110299. 1 indexed citations

Putera, Ikhwanuliman, Benjamin Schrijver, Josianne C. ten Berge, et al.. (2024). A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis. Communications Biology. 7(1). 1114–1114. 4 indexed citations

Maiti, Abhishek, Naval Daver, W. Thomas Johnson, et al.. (2024). ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis. Blood. 144(Supplement 1). 805–805. 1 indexed citations

Born, L. Ingeborgh van den, Jan van Laar, P. Martin van Hagen, et al.. (2024). Somatostatin analogues as a treatment option for cystoid maculopathy in retinitis pigmentosa. BMJ Open Ophthalmology. 9(1). e001722–e001722. 1 indexed citations

Hijnen, DirkJan, Pascal H P de Jong, P.H.M. van der Kuy, et al.. (2023). Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry. JMIR Research Protocols. 12. e43230–e43230. 2 indexed citations

Fragoulis, G., George Βertsias, Bahram Bodaghi, et al.. (2022). Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?. Clinical Immunology. 246. 109186–109186. 5 indexed citations

Hagen, P. Martin van, et al.. (2020). A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet’s disease. Asian Pacific Journal of Allergy and Immunology. 40(4). 435–441. 2 indexed citations

Rosée, Paul La, AnnaCarin Horne, Melissa Hines, et al.. (2019). Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 133(23). 2465–2477. 598 indexed citations breakdown →

10.

Laar, Jan van, et al.. (2018). Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(1). 175–180. 11 indexed citations

11.

Karim, Faiz, Jan Loeffen, Wichor M. Bramer, et al.. (2016). IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatric Rheumatology. 14(1). 18–18. 107 indexed citations

12.

Laar, Jan van, Aniki Rothová, Tom Missotten, et al.. (2015). Diagnosis and treatment of uveitis; not restricted to the ophthalmologist. Journal of Clinical and Translational Research. 1(2). 94–99. 11 indexed citations

13.

Rokx, Casper, Kirsten van Lom, Pieter Sonneveld, et al.. (2015). Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman’s disease complicated by hemophagocytic lymphohistiocytosis. International Journal of Hematology. 103(4). 469–472. 5 indexed citations

14.

Baarsma, Seerp, et al.. (2014). The value of rescreening in primary retinal vasculitis.. Investigative Ophthalmology & Visual Science. 55(13). 5793–5793. 1 indexed citations

15.

Zelm, Menno C. van, King H. Lam, Guus F. Rimmelzwaan, et al.. (2012). Perigranuloma Localization and Abnormal Maturation of B Cells. American Journal of Respiratory and Critical Care Medicine. 187(4). 406–416. 66 indexed citations

16.

Hoorn, Ewout J., Jan van Laar, Jan G. den Hollander, Johan M. Kros, & Esther Brusse. (2010). Three diagnoses become one: a woman with ground-glass attenuation develops fever. Thorax. 65(3). 214–214.

17.

Noordhuis, Paul, U. Holwerda, Jan van Laar, C.L. van der Wilt, & Godefridus J. Peters. (2004). A Non‐Radioactive Sensitive Assay to Measure 5‐Fluorouracil Incorporation into DNA of Solid Tumors. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1481–1484. 6 indexed citations

18.

Laar, Jan van, Youcef M. Rustum, Stephen P. Ackland, C.J. van Groeningen, & Godefridus J. Peters. (1998). Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer. European Journal of Cancer. 34(3). 296–306. 89 indexed citations

19.

Codacci-Pisanelli, Giovanni, C.L. van der Wilt, Herbert M. Pinedo, et al.. (1995). Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice. European Journal of Cancer. 31(9). 1517–1525. 19 indexed citations

20.

Laar, Jan van, et al.. (1995). Modulation of the antitumour activity of cisplatin alone and in combination with 5-fluoro-2'-deoxyuridine by N-phosphonacetyl-l-aspartate in murine colon carcinoma no. 26. European Journal of Cancer. 31(6). 974–976. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact